StockNews.AI
ACB
StockNews.AI
195 days

Aurora Cannabis Announces Fiscal 2025 Third Quarter Results

1. Aurora Cannabis reports record net revenue of $88.2 million, up 37% YoY. 2. Achieves a net income of $31.2 million, up 282% YoY, indicating strong growth.

+76.76%Current Return
VS
+0.62%S&P 500
$3.6802/05 07:03 AM EDTEvent Start

$6.504702/06 02:06 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Very Bullish?

Record growth metrics typically enhance investor confidence, boosting stock prices. Past trends show that such financial improvements correlate well with stock performance.

How important is it?

Strong quarterly results have high potential to influence stock value positively. Historical performance indicates that financial success leads to bullish market sentiment.

Why Short Term?

Immediate results attract investor attention. Financial growth often reflects short-term trading spikes.

Related Companies

NASDAQ | TSX: ACB Reports Total Net Revenue1 of $88.2 Million, up 37% YoY, Including Record Net Revenue1 of $68.1 Million in Global Medical Cannabis, up 51% YoY Generates Record Net Income of $31.2 Million, up 282% YoY, and Record Adjusted EBITDA1 of $23.1 Million, up 316% YoY Achieves Target of Positive Free Cash Flow1 in Q3, Generating $27.4 Million of Free Cash Flow1 Maintains Strong Balance Sheet with $180 Million of Cash and Debt-Free Cannabis Business2 EDMONTON, AB , Feb. 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (theĀ "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third quarter fiscal 2025. "This quarter was record-breaking for Aurora, driven by all-time highs in global medical net revenue1, net income, adjusted EBITDA1, and free cash flow1.

Related News